Biomarin Pharmaceutical and Ascendis Pharma Enter Settlement and License Agreement
BioMarin Pharmaceutical Inc. has entered into a settlement and license agreement with Ascendis Pharma. The agreement is set to take effect on September 24, 2026.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.